1. Treatment of a murine leukemia with spleen cells or sera from allogeneic mice immunized against the tumor;Alexander;Cancer Res.,1966
2. Pharmacovigilance analysis of serious adverse events reported for biologic response modifiers used as prophylaxis against transplant rejection: a real-world Postmarketing experience from the US FDA adverse event reporting system (FAERS);Ali;Int. J. Organ Transplant. Med.,2013
3. Immunology of the mouse mammary tumor virus (MTV): neutralization of MTV by mouse antiserum;Blair;Cancer Res.,1968
4. A comparison of two types of rabbit antithymocyte globulin induction therapy in immunological high-risk kidney recipients: a prospective randomized control study;Burkhalter;PLoS One,2016
5. Exploiting the mutanome for tumor vaccination;Castle;Cancer Res.,2012